Merck breaks ground on $3 billion center of excellence for pharma manufacturing in Virginia
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
The facility is over 79,000 square feet and is equipped with packaging lines
Supply increase to help meet growing global demand
Virginia will be responsible for meeting client needs for both media and commercial analytics.
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Granules India receives 1 observation from USFDA for Chantilly facility
Subscribe To Our Newsletter & Stay Updated